Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Gauthier

Showing results (341-350 of 370) with videos related to

Pageof 37
Sort By:
The Journal of Prevention of Alzheimer'S Disease|June 5, 2025
Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer's diseaseSarah Abbas, Pamela C L Ferreira, Bruna Bellaver, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 9, 2025
Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer's diseaseBruna Bellaver, Guilherme Povala, Pamela C L Ferreira, et al.
Molecular Psychiatry|August 10, 2022
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's diseaseJoão Pedro Ferrari-Souza, Pâmela C L Ferreira, Bruna Bellaver, et al.
Brain Communications|August 16, 2021
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromesRoss W Paterson, Laura A Benjamin, Puja R Mehta, et al.
Nature Medicine|May 29, 2023
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's diseaseBruna Bellaver, Guilherme Povala, Pamela C L Ferreira, et al.
JAMA Neurology|December 12, 2022
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission TomographyJoseph Therriault, Marie Vermeiren, Stijn Servaes, et al.
Nature Communications|July 19, 2022
[<sup>11</sup>C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's diseaseTharick A Pascoal, Mira Chamoun, Elad Lax, et al.
Nature Neuroscience|November 6, 2025
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer's diseaseJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
JAMA Network Open|November 27, 2023
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer DiseaseCristiano Schaffer Aguzzoli, Pâmela C L Ferreira, Guilherme Povala, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 14, 2018
The cost of Alzheimer's disease in China and re-estimation of costs worldwideJianping Jia, Cuibai Wei, Shuoqi Chen, et al.
Pageof 37

Showing results (341-350 of 370) with videos related to

Sort By:
Pageof 37
The Journal of Prevention of Alzheimer'S Disease|June 5, 2025
Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer's diseaseSarah Abbas, Pamela C L Ferreira, Bruna Bellaver, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 9, 2025
Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer's diseaseBruna Bellaver, Guilherme Povala, Pamela C L Ferreira, et al.
Molecular Psychiatry|August 10, 2022
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's diseaseJoão Pedro Ferrari-Souza, Pâmela C L Ferreira, Bruna Bellaver, et al.
Brain Communications|August 16, 2021
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromesRoss W Paterson, Laura A Benjamin, Puja R Mehta, et al.
Nature Medicine|May 29, 2023
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's diseaseBruna Bellaver, Guilherme Povala, Pamela C L Ferreira, et al.
JAMA Neurology|December 12, 2022
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission TomographyJoseph Therriault, Marie Vermeiren, Stijn Servaes, et al.
Nature Communications|July 19, 2022
[<sup>11</sup>C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's diseaseTharick A Pascoal, Mira Chamoun, Elad Lax, et al.
Nature Neuroscience|November 6, 2025
Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer's diseaseJoão Pedro Ferrari-Souza, Guilherme Povala, Nesrine Rahmouni, et al.
JAMA Network Open|November 27, 2023
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer DiseaseCristiano Schaffer Aguzzoli, Pâmela C L Ferreira, Guilherme Povala, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 14, 2018
The cost of Alzheimer's disease in China and re-estimation of costs worldwideJianping Jia, Cuibai Wei, Shuoqi Chen, et al.
Pageof 37